Silydianin — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Silydianin

Provisional Moderate Scorecompound

Hermetica Superfood Encyclopedia

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

Silydianin is a flavonolignan compound found in milk thistle that functions as part of the silymarin complex. It demonstrates antioxidant activity by reducing reactive oxygen species production and shows potential antiviral properties.

Screened PMID Records
Reported Benefits
Pending
Synergy Review
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Public Score StatusProvisional Moderate
Primary Keywordsilydianin benefits
Silydianin close-up macro showing natural texture and detail — rich in hepatoprotective, antioxidant, anti-inflammatory
Silydianin — botanical close-up

Origin & History

Silydianin growing in Mediterranean — natural habitat
Natural habitat

Silydianin is a flavonolignan compound isolated from the seeds of Silybum marianum (milk thistle), a plant native to the Mediterranean region. It forms part of the silymarin complex alongside silybin and silychristin, typically extracted via solvent methods from the plant's fruits or seeds.

While no direct historical data exists on isolated silydianin, Silybum marianum (milk thistle) seeds have been used in traditional European herbal medicine for liver disorders since ancient times. The silymarin complex was popularized in the 20th century for hepatoprotection.Traditional Medicine

Research Narrative (Provisional)

Clinical evidence primarily evaluates silymarin complex rather than isolated silydianin. A phase II RCT (PMID:31536511) testing silymarin in NASH patients found no significant histological improvement, while a meta-analysis (PMID:30477860) showed silymarin improved metabolic status in T2DM. A 4-month RCT (PMID:17072885) demonstrated improvements in fasting glucose and HbA1c with 600mg/day silymarin.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

Silydianin is a pure flavonolignan compound (C₂₅H₂₂O₁₀, molecular weight ~482.44 g/mol), not a food ingredient, and therefore carries no conventional macronutrient or micronutrient profile (zero protein, fat, carbohydrate, fiber, or caloric value in its isolated form). It is one of the minor constituents of silymarin, the standardized extract from milk thistle (Silybum marianum) seeds, typically comprising approximately 5–10% of the total silymarin complex by weight, compared to silybin which dominates at ~50–70%. As a bioactive compound, silydianin contains a phenylchromane skeleton with multiple hydroxyl groups conferring its antioxidant capacity. Oral bioavailability of silydianin, like other flavonolignans, is generally low due to limited aqueous solubility, first-pass hepatic metabolism, and poor intestinal absorption; studies on the broader silymarin complex suggest systemic bioavailability of individual flavonolignans typically falls below 1–5% from standard formulations, with phospholipid complexes (e.g., Siliphos) improving absorption by up to 4–5 fold. No standalone pharmacokinetic data specific to isolated silydianin in humans is currently published. In commercial milk thistle extracts standardized to 70–80% silymarin, silydianin concentration is estimated at roughly 35–80 mg per 1,000 mg extract. No dietary reference intakes (DRIs) or established daily values exist for silydianin.

Reported Mechanism (Provisional)

Mechanism of Action

Silydianin acts as an antioxidant by scavenging reactive oxygen species and reducing oxidative stress in hepatocytes. The compound modulates cellular antioxidant enzyme systems and may interfere with viral replication through inhibition of viral RNA synthesis. It works synergistically with other silymarin components including silybin and silychristin to enhance hepatoprotective effects.

Clinical Narrative (Provisional)

Limited clinical research exists specifically on silydianin as an isolated compound. A 48-week randomized controlled trial (n=78) examining silymarin complex containing silydianin showed no significant histological improvement in NASH patients. Most evidence comes from in vitro studies demonstrating antioxidant and antiviral activities. The clinical efficacy of silydianin alone remains poorly established compared to the broader silymarin complex.

Also Known As

2,3-DehydrosilydianinSilymarin DFlavonolignan DMilk thistle flavonolignanSilybum compound DHepatoprotective flavonoid D

Explore the Full Encyclopedia

Browse evidence-gated ingredient records with transparent editorial and citation standards.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.